Alterity Therapeutics Ltd ADR (ATHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | 12-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,474 | 2,954 | 8,289 | 8,028 | 10,619 |
| Receivables | 2,550 | 3,702 | 2,651 | 3,899 | 5,834 |
| Other current assets | 5,682 | 137 | 1,544 | 2,404 | 1,756 |
| TOTAL | $29,706 | $6,793 | $12,484 | $14,331 | $18,209 |
| Non-Current Assets | |||||
| PPE Net | N/A | 10 | 157 | N/A | 164 |
| Other Non-Current Assets | 0 | 65 | 0 | 0 | 0 |
| TOTAL | $N/A | $75 | $157 | $N/A | $164 |
| Total Assets | $29,807 | $6,868 | $12,607 | $14,461 | $18,390 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,668 | 1,336 | 3,030 | 2,366 | 2,368 |
| Other current liabilities | 567 | 382 | 414 | 544 | 491 |
| TOTAL | $2,289 | $1,770 | $3,524 | $2,928 | $2,950 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 28 | 0 | 50 | 13 |
| TOTAL | $N/A | $28 | $N/A | $50 | $13 |
| Total Liabilities | $2,346 | $1,798 | $3,558 | $2,977 | $3,033 |
| Shareholders' Equity | |||||
| Common Shares | 170,286 | 145,556 | 146,344 | 140,079 | 144,046 |
| Retained earnings | -146,286 | -143,920 | -140,447 | -131,383 | -131,362 |
| Other shareholders' equity | 3,460 | 3,435 | 3,152 | 2,787 | 2,674 |
| TOTAL | $27,460 | $5,070 | $9,049 | $11,483 | $15,358 |
| Total Liabilities And Equity | $29,806 | $6,868 | $12,607 | $14,460 | $18,391 |